| |
I tried to search recap once but was prompted for a password. I do not know what to make of this. It appears that Paxene approval for breast cancer would have been a simple matter. Frankly, I'm a bit numb to any more Paxene information. What is Ivax without Paxene is the question. If Gabelli is recommending it at $10.00, is Paxene really worth $3.00 x 121,000,000 = $363,000,000 in present dollars? I guess it is. The market sure says so. HOWEVER, if Paxene is approved, it is going to be a green Christmas for me. This doesn't even take into account any future prospects for Ivax generic drugs.
Dizzy,
Jackson |
|
